Back
Amicus Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
FOLD
Amicus Therapeutics
Last Price:
$6.44
Seasonality Move:
24.66%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.08 | Buy |
| 20-day SMA: | 6.63 | Sell |
| 50-day SMA: | 7.49 | Sell |
| 200-day SMA: | 9.63 | Sell |
| 8-day EMA: | 6.2 | Buy |
| 20-day EMA: | 6.54 | Sell |
| 50-day EMA: | 7.33 | Sell |
| 200-day EMA: | 9.14 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 44.06 | Sell |
| Chaikin Money Flow: | 7834312 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.14 - 7.16) | Sell |
| Bollinger Bands (100): | (7.22 - 9.76) | Sell |
Amicus Therapeutics Technical Analysis
| May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.43 while FOLD 8-day simple moving average is 6.08, which is a Buy signal.
-
The stock price of FOLD is 6.43 while Amicus Therapeutics 20-day SMA is 6.63, which makes it a Sell.
-
Amicus Therapeutics 50-day simple moving average is 7.49 while FOLD share price is 6.43, making it a Sell technically.
-
FOLD stock price is 6.43 and Amicus Therapeutics 200-day simple moving average is 9.63, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
32
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $6.43. The Score for FOLD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2B
Price in USD:
6.43
Share Volume:
8.1M
Amicus Therapeutics 52-Week Range
52-Week High:
12.65
52-Week Low:
5.81
Sell
32
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 6.43 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.43 while FOLD 8-day exponential moving average is 6.20, which is a Buy signal.
-
The stock price of FOLD is 6.43 while Amicus Therapeutics 20-day EMA is 6.54, which makes it a Sell.
-
Amicus Therapeutics 50-day exponential moving average is 7.33 while FOLD share price is 6.43, making it a Sell technically.
-
FOLD stock price is 6.43 and Amicus Therapeutics 200-day simple moving average is 9.14, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.09 per share, and an increase next year of $0.35 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Amicus Therapeutics is a Sell
-
Amicus Therapeutics Relative Strength Index (RSI) is 44.06, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (6.14 - 7.16), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (7.22 - 9.76), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.